title: Implementation of consensus guidelines for the follow-up of positive blood cultures.
abstract: OBJECTIVE
  Assess the effect and use of resources associated with implementation of a program for the systematic follow-up of positive blood cultures.
  
  
  METHODS
  Prospective epidemiologic study.
  
  
  METHODS
  Tertiary-care military medical center.
  
  
  METHODS
  All positive blood cultures (BC) were reported via E-mail to an infectious disease specialist as soon as growth was noted. This individual reviewed all Gram stains, clinical data, and antibiotic information on these patients.
  
  
  RESULTS
  From June 26, 1994, through January 25, 1995, there were 3,121 BCs drawn, of which 199 (6.4%) were positive from 145 episodes. Sixty-three episodes involved probable contaminants, and 82 episodes were considered true bacteremias. Six patients with true bacteremia died, two were transferred, and three were discharged within 24 hours of drawing the positive BC. Of the remaining 71 true bacteremias, 9 patients were on inadequate empiric therapy, as judged by the final organism susceptibilities. Changes in empiric therapy were recommended for five of the nine episodes and were implemented by the primary physicians in each case. Each of the changes resulted in improved coverage (as judged by the final identification and susceptibilities).
  
  
  CONCLUSIONS
  This program has improved the quality of care at Keesler Medical Center at the cost of one additional hour of consultant time per week.
authors.affiliation: Department of Internal Medicine, Keesler Medical Center, Keesler AFB, MS, USA.
authors.forename: T
authors.initials: T
authors.lastname: Herchline
authors.forename: S
authors.initials: S
authors.lastname: Gros
mesh_terms: D000328:Adult; D000359:Aftercare / Q000592:standards; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology; D002648:Child; D003428:Cross Infection / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology; D017723:Drug Utilization Review; D006772:Hospitals, Military; D006801:Humans; D017053:Infection Control / Q000592:standards*; D008826:Microbial Sensitivity Tests; D008922:Mississippi; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D017749:Total Quality Management
chemical_list: D000900:Anti-Bacterial Agents